SARS CoV 2 News and Research

RSS

Pioneering diagnostics platform changes the way COVID-19 is detected

Montreal-based Two-Photon Research Inc. announces CAST, a diagnostics platform that changes the way viruses are detected. The CAST platform uses TPR’s patented Aptamer Molecular Photonic Beacon™ that photonically interfaces with smartphones.

10 Dec 2020

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

Risk of COVID infection in health care workers is driven by community exposure

Nurses only group with higher risk once community exposure considered. Largest cohort of health care worker risk for SARS CoV-2. Only high-flow oxygen therapy and hemodialysis linked to more antibodies to SARS-CoV-2.

10 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Researchers present new project for detection of SARS-COV-2 virus in indoor air

Researchers at the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) and the Universitat de València (UV) have presented the AIRCOV project for the detection of the SARS-COV-2 virus in indoor air.

9 Dec 2020

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Researchers in the Henry Samueli School of Engineering at the University of California, Irvine announced promising results in the development of a noninvasive at-home antigen test to detect the spike of SARS-CoV-2 proteins in saliva.

9 Dec 2020

Study links insulin resistance and ozone exposure to interstitial lung disease

People with pre-diabetes or diabetes who live in ozone-polluted areas may have an increased risk for an irreversible disease with a high mortality rate.

9 Dec 2020

New consortium aims to understand principles underlying the formation of coronaviruses

The University of California, Riverside, is the recipient of a 2021 UC Multicampus Research Programs and Initiatives, or MRPI, award allowing the campus to put together a UC Coronavirus Assembly Research Consortium.

9 Dec 2020

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Researchers in the United States have conducted a study suggesting that a small proportion of people living in Seattle were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – by around late March/early April 2020.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

The impact of COVID-19 on emergency medical services: a case study

A team of researchers based in Turkey has now studied the pandemic's effect on emergency medical services (EMS). Their study, titled "Effects of COVID‐19 pandemic on emergency medical services," was published in the latest issue of The International Journal of Clinical Practice.

9 Dec 2020

Obesity increases the risk of severe COVID-19, study finds

Researchers reveal that being overweight and obese are common risk factors for developing severe COVID-19. However, they suggested further assessment of metabolic parameters, including body mass index (BMI), waist-hip ratio, and insulin levels, to estimate the risk.

9 Dec 2020

Researchers develop analytical model to gauge SARS-CoV-2 transmission dynamics in schools

Research highlight the risk of virus spread in schools in the Netherlands. Since most schools across countries have resumed in-person or face-to-face classes, knowing the virus's risk and transmission dynamics in this context is crucial.

9 Dec 2020

The effects of cigarette smoke and COPD on SARS-CoV-2 infection

Researchers have revealed some of the effects of cigarette smoke and chronic obstructive pulmonary disease (COPD) on SARS-CoV-2 infection.

9 Dec 2020

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

The University of Louisville has received funding from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent serious viral respiratory infections such as COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL.

9 Dec 2020

What safety measures have food suppliers implemented in response to COVID-19?

Researchers surveyed small to large food companies in 16 countries on food safety attributes and emergency plans. They found that less than half the food companies had documented putting emergency plans in place for pandemics and public health crises.

9 Dec 2020

Neutrophils may play a key role in COVID-19-related thrombosis

A team of researchers in Italy have published a study suggesting that rather than platelets, neutrophils could be playing the lead role in thrombotic complications associated with COVID-19.

9 Dec 2020

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public’s willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.

9 Dec 2020

Predicting SARS-CoV-2 protein sequences

SARS-CoV-2, the causative agent of COVID-19, consists of an assembly of proteins that determine its infectious and immunological behavior.

9 Dec 2020

SARS CoV 2 News and Research

Pioneering diagnostics platform changes the way COVID-19 is detected

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

Risk of COVID infection in health care workers is driven by community exposure

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Researchers present new project for detection of SARS-COV-2 virus in indoor air

UCI researchers develop noninvasive, at-home saliva test to detect COVID-19

Study links insulin resistance and ozone exposure to interstitial lung disease

New consortium aims to understand principles underlying the formation of coronaviruses

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

The impact of COVID-19 on emergency medical services: a case study

Obesity increases the risk of severe COVID-19, study finds

Researchers develop analytical model to gauge SARS-CoV-2 transmission dynamics in schools

The effects of cigarette smoke and COPD on SARS-CoV-2 infection

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

What safety measures have food suppliers implemented in response to COVID-19?

Neutrophils may play a key role in COVID-19-related thrombosis

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Predicting SARS-CoV-2 protein sequences

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News